BESREMI

Immunostimulants; pre-filled syringes containing PEGylated interferons for medical purposes; anticancer pharmaceuticals; medicines for human purposes of treating cancers, polycythemia vera (PV) and other myeloproliferative neoplasms (MPNs); western medicine, namely, ropeginterferon alfa-2b; active pharmaceutical ingredients for active pharmaceutical ingredients of ropeginterferon alfa-2b for treating cancers, PV and other MPNs; medicinal agent for human use, namely, pharmaceuticals for treating cancers or viral infections; biological preparations for medical purposes, namely, ropeginterferon alfa-2b; chemical preparations for medical purposes, namely, for cancers, PV and other MPNs; chemical-pharmaceutical preparations, namely, for treating cancers, PV and other MPNs; albuminous preparations for medical purposes; chemical preparations for pharmaceutical purposes, namely, for treating cancers, PV and other MPNs; pharmaceutical preparations for treating cancers, PV and other MPNs